Pioglitazone: a promising therapy for psoriasis

作者:

DOI: 10.1111/J.1365-2133.2005.06369.X

关键词: PioglitazonePsoriasisDermatologyMEDLINEChronic diseaseMedicine

摘要:

参考文章(4)
H. A. Pershadsingh, Treatment of psoriasis with troglitazone therapy. Archives of Dermatology. ,vol. 134, pp. 1304- 1305 ,(1998) , 10.1001/ARCHDERM.134.10.1304
Narasimharao Bhagavathula, Kamalakar C. Nerusu, Ashish Lal, Charles N. Ellis, Amar Chittiboyina, Mitchell A. Avery, Christopher I. Ho, Stephen C. Benson, Harrihar A. Pershadsingh, Theodore W. Kurtz, James Varani, Rosiglitazone inhibits proliferation, motility, and matrix metalloproteinase production in keratinocytes. Journal of Investigative Dermatology. ,vol. 122, pp. 130- 139 ,(2004) , 10.1046/J.0022-202X.2003.22111.X
Charles N. Ellis, James Varani, Gary J. Fisher, Mary E. Zeigler, Harrihar A. Pershadsingh, Stephen C. Benson, Yiqing Chi, Theodore W. Kurtz, Troglitazone Improves Psoriasis and Normalizes Models of Proliferative Skin Disease Archives of Dermatology. ,vol. 136, pp. 609- 616 ,(2000) , 10.1001/ARCHDERM.136.5.609
Kathy Ann LaCivita, Gustavo Villarreal, Differences in lipid profiles of patients given rosiglitazone followed by pioglitazone. Current Medical Research and Opinion. ,vol. 18, pp. 363- 370 ,(2002) , 10.1185/030079902125001038